Annals of Oncology

1

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

Dingemans, A.- M. C., de Langen, A. J., van den Boogaart, V., Marcus, J. T., Backes, W. H., Scholtens, H. T. G. M., van Tinteren, H., Hoekstra, O. S., Pruim, J., Brans, B., Thunnissen, F. B., Smit, E.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 383 KB

english, 2011

2

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

Rieger, M., Osterborg, A., Pettengell, R., White, D., Gill, D., Walewski, J., Kuhnt, E., Loeffler, M., Pfreundschuh, M., Ho, A. D.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 129 KB

english, 2011

3

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer

DeCensi, A., Guerrieri-Gonzaga, A., Gandini, S., Serrano, D., Cazzaniga, M., Mora, S., Johansson, H., Lien, E. A., Pruneri, G., Viale, G., Bonanni, B.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 156 KB

english, 2011

4

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Dawood, S., Merajver, S. D., Viens, P., Vermeulen, P. B., Swain, S. M., Buchholz, T. A., Dirix, L. Y., Levine, P. H., Lucci, A., Krishnamurthy, S., Robertson, F. M., Woodward, W. A., Yang, W. T., Ueno

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 105 KB

english, 2011

5

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Metro, G., Foglietta, J., Russillo, M., Stocchi, L., Vidiri, A., Giannarelli, D., Crino, L., Papaldo, P., Mottolese, M., Cognetti, F., Fabi, A., Gori, S.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 284 KB

english, 2011

6

Predictors of state-of-the-art management of early breast cancer in Switzerland

Ess, S., Joerger, M., Frick, H., Probst-Hensch, N., Vlastos, G., Rageth, C., Lutolf, U., Savidan, A., Thurlimann, B.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 94 KB

english, 2011

7

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

Ngeow, J., Lim, W. T., Leong, S. S., Ang, M. K., Toh, C. K., Gao, F., Chowbay, B., Tan, E. H.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 107 KB

english, 2011

8

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group

Cahu, X., Bodet-Milin, C., Brissot, E., Maisonneuve, H., Houot, R., Morineau, N., Solal-Celigny, P., Godmer, P., Gastinne, T., Moreau, P., Moreau, A., Lamy, T., Kraber-Bodere, F., Le Gouill, S.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 194 KB

english, 2011

9

Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women

Minig, L., Franchi, D., Boveri, S., Casadio, C., Bocciolone, L., Sideri, M.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 231 KB

english, 2011

10

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer

Dahabreh, I. J., Linardou, H., Kosmidis, P., Bafaloukos, D., Murray, S.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 178 KB

english, 2011

11

Coffee and cancers of the upper digestive and respiratory tracts: meta-analyses of observational studies

Turati, F., Galeone, C., La Vecchia, C., Garavello, W., Tavani, A.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 168 KB

english, 2011

12

Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information

Chou, W.- C., Hou, H.- A., Liu, C.- Y., Chen, C.- Y., Lin, L.- I., Huang, Y.- N., Chao, Y.- C., Hsu, C.- A., Huang, C.- F., Tien, H.- F.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 638 KB

english, 2011

13

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)

Conconi, A., Martinelli, G., Lopez-Guillermo, A., Zinzani, P. L., Ferreri, A. J. M., Rigacci, L., Devizzi, L., Vitolo, U., Luminari, S., Cavalli, F., Zucca, E.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 177 KB

english, 2011

14

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Smith, I. E., Pierga, J.- Y., Biganzoli, L., Cortes-Funes, H., Thomssen, C., Pivot, X., Fabi, A., Xu, B., Stroyakovskiy, D., Franke, F. A., Kaufman, B., Mainwaring, P., Pienkowski, T., De Valk, B., Kw

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 111 KB

english, 2011

15

Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer

Wildiers, H., Neven, P., Christiaens, M. R., Squifflet, P., Amant, F., Weltens, C., Smeets, A., van Limbergen, E., Debrock, G., Renard, V., Van Eenoo, L., Wynendaele, W., Paridaens, R.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 149 KB

english, 2011

16

Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer

Martoni, A. A., Di Fabio, F., Pinto, C., Castellucci, P., Pini, S., Ceccarelli, C., Cuicchi, D., Iacopino, B., Di Tullio, P., Giaquinta, S., Tardio, L., Lombardi, R., Fanti, S., Cola, B.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 213 KB

english, 2011

17

Is the Ki-67 labelling index ready for clinical use?

Jonat, W., Arnold, N.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 49 KB

english, 2011

18

Treatment of cancer with drugs: a controversy

Guedea, F., Macia, M., Sanchez Calzado, J. A., Ramos, A., Lopez Torrecilla, J. L., Herruzo, I., Contreras, J., Romero, J., Willisch, P.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 37 KB

english, 2011

19

Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis

Scholz, M., Engert, A., Franklin, J., Josting, A., Diehl, V., Hasenclever, D., Loeffler, M.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 231 KB

english, 2011

20

Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region

Lam, E. K. K., Batty, G. D., Huxley, R. R., Martiniuk, A. L. C., Barzi, F., Lam, T. H., Lawes, C. M. M., Giles, G. G., Welborn, T., Ueshima, H., Tamakoshi, A., Woo, J., Kim, H. C., Fang, X., Czernicho

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 181 KB

english, 2011

21

The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum

Lonning, P. E.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 265 KB

english, 2011

22

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy

Besse, B., Massard, C., Haddad, V., Andre, F., Dunant, A., Pirker, R., Olaussen, K. A., Brambilla, E., Fouret, P., Soria, J. C.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 119 KB

english, 2011

23

Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma

Barrington, S. F., MacKewn, J. E., Schleyer, P., Marsden, P. K., Mikhaeel, N. G., Qian, W., Mouncey, P., Patrick, P., Popova, B., Johnson, P., Radford, J., O'Doherty, M. J.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 333 KB

english, 2011

24

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

Potthoff, K., Hofheinz, R., Hassel, J. C., Volkenandt, M., Lordick, F., Hartmann, J. T., Karthaus, M., Riess, H., Lipp, H. P., Hauschild, A., Trarbach, T., Wollenberg, A.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 353 KB

english, 2011

25

How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary

Uzan, C., Kane, A., Rey, A., Gouy, S., Pautier, P., Lhomme, C., Duvillard, P., Morice, P.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 68 KB

english, 2011

26

Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?

Jung, Y. W., Seong, S. J., Kim, J. W.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 33 KB

english, 2011

27

A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer

Schneeweiss, A., Marme, F., Ruiz, A., Manikhas, A. G., Bottini, A., Wolf, M., Sinn, H.- P., Mansouri, K., Kennedy, L., Bauknecht, T.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 119 KB

english, 2011

28

Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet

Kamo, N., Dandapani, S. V., Miksad, R. A., Houlihan, M. J., Kaplan, I., Regan, M., Greenfield, T. K., Sanda, M. G.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 216 KB

english, 2011

29

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Joerger, M., Matter-Walstra, K., Fruh, M., Kuhnel, U., Szucs, T., Pestalozzi, B., Schwenkglenks, M.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 186 KB

english, 2011

30

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer

Senan, S., Cardenal, F., Vansteenkiste, J., Stigt, J., Akyol, F., De Neve, W., Bakker, J., Dupont, J.- M., Scagliotti, G. V., Ricardi, U., van Meerbeeck, J. P.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 148 KB

english, 2011

31

Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study

Merlano, M., Russi, E., Benasso, M., Corvo, R., Colantonio, I., Vigna-Taglianti, R., Vigo, V., Bacigalupo, A., Numico, G., Crosetto, N., Gasco, M., Lo Nigro, C., Vitiello, R., Violante, S., Garrone, O

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 145 KB

english, 2011

32

Reply to Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?

Sideri, M., Minig, L., Franchi, D., Casadio, C., Boveri, S., Bocciolone, L.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 29 KB

english, 2011

33

Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen

Picardi, M., Soricelli, A., Grimaldi, F., Nicolai, E., Gallamini, A., Pane, F.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 505 KB

english, 2011

34

Editorial Board

Journal:

Annals of Oncology

Year:

2011

File:

PDF, 79 KB

2011

35

Volume 22; Issue 3

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Predictors of state-of-the-art management of early breast cancer in Switzerland

Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group

Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer

Coffee and cancers of the upper digestive and respiratory tracts: meta-analyses of observational studies

Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancer

Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer

Is the Ki-67 labelling index ready for clinical use?

Treatment of cancer with drugs: a controversy

Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis

Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region

The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy

Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary

Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?

A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer

Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer

Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study

Reply to Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?

Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen

Editorial Board

Table of Contents